Objectives: Absence of somatosensory evoked potentials is considered a nearly perfect predictor of poor outcome after cardiac arrest. However, reports of good outcomes despite absent somatosensory evoked potentials and high rates of withdrawal of life-sustaining therapies have raised concerns that estimates of the prognostic value of absent somatosensory evoked potentials may be biased by self-fulfilling prophecies. We aimed to develop an unbiased estimate of the false positive rate of absent somatosensory evoked potentials as a predictor of poor outcome after cardiac arrest. Data Sources: PubMed. Study Selection: We selected 35 studies in cardiac arrest prognostication that reported somatosensory evoked potentials. Data Extraction: In each study, we identified rates of withdrawal of life-sustaining therapies and good outcomes despite absent somatosensory evoked potentials. We appraised studies for potential biases using the Quality in Prognosis Studies tool. Using these data, we developed a statistical model to estimate the false positive rate of absent somatosensory evoked potentials adjusted for withdrawal of life-sustaining therapies rate. Data Synthesis: Two-thousand one-hundred thirty-three subjects underwent somatosensory evoked potential testing. Five-hundred ninety-four had absent somatosensory evoked potentials; of these, 14 had good functional outcomes. The rate of withdrawal of life-sustaining therapies for subjects with absent somatosensory evoked potential could be estimated in 14 of the 35 studies (mean 80%, median 100%). The false positive rate for absent somatosensory evoked potential in predicting poor neurologic outcome, adjusted for a withdrawal of life-sustaining therapies rate of 80%, is 7.7% (95% CI, 4-13%). Conclusions: Absent cortical somatosensory evoked potentials do not infallibly predict poor outcome in patients with coma following cardiac arrest. The chances of survival in subjects with absent somatosensory evoked potentials, though low, may be substantially higher than generally believed. (Crit Care Med 2018; 46:e1213-e1221) W ithdrawal of life-sustaining therapies (WLST) due to poor neurologic prognosis is the most common proximate cause of in-hospital death after cardiac arrest (1, 2) . Absence of short-latency cortical median nerve somatosensory evoked potentials (SSEPs) are considered by many experts an unequivocal predictor of poor outcome in cardiac arrest, with false positive rate (FPR) for making such predictions given as 0.4-0.7% in society guidelines (3, 4) However, recent studies following the introduction of targeted temperature management (TTM) suggest that, although rare, good neurologic outcomes can occur in cardiac arrest survivors with initially absent SSEPs. Two such examples have been cited in previous reviews (5, 6) . These cases, coupled with reports of high rates of early WLST in patients with absent SSEPs, have raised concern that estimates of the FPR for SSEPs testing may be confounded by self-fulfilling prophecies (7, 8) .
We hypothesized that estimates in the literature for the FPR of SSEPs as a predictor of poor neurologic outcome after cardiac arrest are biased by the fact that WLST almost invariably leads to death. We conducted a systematic review of studies that report the rate of good and poor outcomes in cardiac arrest subjects who were managed with TTM and had absent bilateral SSEPs. Finally, we developed a statistical method to adjust for the rate of early WLST, in order to calculate an unbiased estimate of the FPR for absent SSEPs.
MATERIALS AND METHODS
Search Strategy, Study Selection, and Data Abstraction A literature search was performed on April 12, 2017, using PubMed (January 1960 to April 2017) for original and full-text reports in English, German, French, Chinese, and Spanish. The search terms used were "heart arrest" or "death (sudden cardiac)" or "cardiopulmonary resuscitation" or "hypoxia-ischemia, brain" or "hypoxic-ischemic, brain" or "cardiac arrest" and "targeted temperature management" or "TTM," "hypothermia" and "prognosis" or "prognostic" or "SSEP" or "N20" or "evoked potentials." Corresponding authors of the articles selected were contacted whenever there was missing information or if clarification about the data was needed. In cases with potential for subject overlap in publications by the same group of investigators, the corresponding author was contacted for clarification. If overlap was present, only the study with the largest number of subjects enrolled was included. Final study selection and data abstraction were performed by study investigators (E.A., M.B.W.) using a standardized data collection form. Any disagreements were discussed until reaching consensus. Potential for bias in selected studies was appraised using the Quality in Prognosis Studies (supplementary materials, Supplemental Digital Content 1, http://links.lww.com/ CCM/E10). In an effort to identify all published cases of absent SSEPs with subsequent good neurologic outcome, we performed a secondary review of citations from included studies.
Inclusion Criteria
Eligible studies involved comatose adult (age 16 yr old or older) cardiac arrest survivors with return of spontaneous circulation (ROSC) and out-of-hospital or in-hospital arrest treated with TTM (normothermia at 36°C or therapeutic hypothermia at 32-34°C). Only studies describing neurologic functional outcomes and SSEPs results were included. When studies included a mixed group of subjects managed with or without TTM, only data from subjects managed with TTM were included in the final analysis. Case reports describing a single patient good outcome despite initially absent SSEPs were included in order to count the number of such cases reported in the literature to date. However, our subsequent statistical analysis of the FPR of SSEPs was restricted to cohort studies.
Exclusion Criteria
Animal studies and clinical studies that involved pediatric subjects (age < 16 yr old) or subjects with etiology of coma other than cardiac arrest were excluded. Articles were excluded if they were best categorized as reviews, editorials, letters to the editor, conference abstracts, or unpublished studies.
In the reviewed studies, SSEPs were categorized as "absent" if there were bilaterally absent cortical (N20) responses, "present" if there were unilateral or bilateral cortical responses present, or "indeterminate" in case the presence of a cortical response was indeterminate. For the purposes of this systematic review, the term "absent SSEPs" refers to absent shortlatency cortical (N20) median nerve SSEP responses. Poor outcome was defined as severe neurologic deficits, persistent vegetative state, or death.
Statistical Analysis
Estimation of FPR Correcting for Self-Fulfilling Prophecies. We use binomial probability models to estimate the FPR of absent SSEPs corrected for bias due to self-fulfilling prophecies. We define the natural FPR (nFPR) as the proportion of subjects with initially absent SSEPs who would eventually achieve a good neurologic recovery in a setting where lifesustaining therapy is continued indefinitely. nFPR cannot be observed directly in the presence of self-fulfilling prophecies. However, nFPR can be estimated from 1) the observed FPR (oFPR) predictions in the literature and 2) the rate of self-fulfilling prophecies, that is, the rate of WLST in cases of absent SSEPs, denoted withdrawal of life support rate (WLSTR).
Early WLST (i.e., WLSTR > 0) will tend to make the oFPR less than the nFPR, oFPR less than or equal to nFPR: early WLST reduces the chance of a good outcome in cases that might otherwise have recovered. This is because two independent events need to occur for a subject with negative SSEPs to achieve a good outcome. First, the inciting injury must be survivable, in other words, the negative SSEPs result must represent a "false alarm;" by definition the rate at which this occurs is nFPR. Second, the subject must escape becoming the Critical Care Medicine www.ccmjournal.org e1215 object of a self-fulfilling prophecy; this occurs with probability 1 WLSTR − ( ). The probability of a good outcome despite an absent SSEPs result is thus oFRP= 1 WLSTR nFPR − ( )( ).
Equivalently, the nFPR (corrected for the bias introduced by self-fulfilling prophecies) is nFPR=oFPR/ 1 WLSTR − ( ).
Extending these calculations, in a cohort of n subjects with absent SSEPs, the probability that a "bad" outcome occurs once is thus 1 1 WLSTR nFPR − − ( )( ), and the probability that all outcomes are bad is p n = (
We use this latter calculation to estimate the probability that, in any given small cohort, all subjects with absent SSEPs experience poor outcomes.
RESULTS
Literature search yielded 676 manuscripts; 11 additional studies were identified through secondary reference review. Screening for studies restricted to the pediatric population, reviews, or editorials, or studies not focused on prognostication led to exclusion of 509 studies (Fig. 1) . Duplicate subject inclusion between publications was present in 12 studies from four groups of investigators, and nine studies were excluded. One hundred thirty-four studies did not fulfill inclusion criteria based on lack of SSEPs use for prognostication and because the study was not focused on prognostication. Thirty-five studies were included in the final review. The study characteristics of the included studies are summarized in Table 1) . Two of these subjects had absent SSEPs during hypothermia and recovered cortical responses within 72 hours from ROSC during normothermia. We included these cases based on claims in the recent literature that therapeutic hypothermia at 32-34°C has no impact on SSEP amplitude or presence (40, 41) . We restrict our subsequent analysis of the FPR associated with absent SSEPs to the nine subjects from cohort studies, to allow accurate determination of the denominator of the estimated rate estimate.
WLST
The rate of WLST due to bilateral absent SSEPs was reported explicitly in three studies: 50%, 79%, and 82% (7, 8, 13) . Five studies reported a policy of systematic WLST in all cases (100%) of absent SSEPs (10, 11, 22, 35, 38) . Ten studies did not explicitly report the WLST rate but described a "multimodal approach" protocol to prognostication that included absent SSEPs results for WLST decisions (5, 6, 15, 16, 19, 28, 29, 33, 34, 36) . Nevertheless, four of these explicitly recommended WLST in subjects who had absent SSEPs, thus we considered their WLST for absent SSEPs as 100% (19, 28, 29, 36) . One study did not disclose SSEPs results to the treating team (31) . Two studies did not have any cases of WLST due to neurologic reasons (31, 39) . Eight studies did not describe the protocol for WLST (14, 17, 18, 20, 21, 24, 25, 30) . Thus, the estimated mean rate of WLST for cases with absent SSEPs across 14 studies with available information about WLST procedures was 80% (median 100%), with a range between 0 and 100 (7, 8, 10, 11, 13, 19, 22, 28, 29, 31, 35, 36, 38, 39) .
Appraisal of Risk of Bias
The risk of bias ratings is summarized in Figure 2 . Attrition and study confounding were the domains with the largest risk of bias, both having 26 studies with high risk of bias. The studies judged to have high bias in these domains did not systematically avoid WLST before 1 week after ROSC (attrition bias) or had SSEPs results available to the treating clinicians responsible for WLST decisions (study confounding bias). Most studies had low bias for study participation, prognostic factor measurement, and outcome measurement ( Table s2 , Supplemental Digital Content 3, http://links.lww.com/CCM/E12). One study was in the acute rehabilitation setting, and therefore was scored as having high risk for bias in study participation and moderate risk for bias in outcome assessments (20) . One study did not have any cases with WLST (low attrition and low study confounding bias), and one study did not have any WLST for neurologic reasons but allowed withdrawal of inotropic support (moderate attrition bias and low study confounding bias) (31, 39) . Figure 3 shows our statistical estimates of the nFPR for absent SSEPs, corrected for the rate of self-fulfilling prophecies, along with the 95% certainty interval. The rate of WLST in response to absent SSEPs, designated WLSTR, varied across various studies in our systematic review, therefore we present nFPR as a function of WLSTR. The estimates are calculated using all subjects identified in our systematic review who had bilaterally absent SSEPs with the exception of case reports. The oFPR is 9/589 = 1.5%. This represents the FPR without adjusting for the rate of WLST. In the absence of self-fulfilling prophecies (i.e., if WLSTR = 0), the estimated nFPR coincides with the observed rate (left-hand side of the plot). However, in most studies, WLSTR is greater than 80% (gray shaded region). In this portion of the plot, the small percentage of observed good outcomes despite high rates of WLST leads to substantially higher estimates of the underlying nFPR. At the same time, the estimates necessarily become more uncertain (wider confidence regions). To obtain a single summary number that approximately reflects practices across published studies, we take as an overall (conservative) estimate the value of nFPR resulting when the rate of early WLST is 80%. The nFPR value is 7.7% (CI, 4-13%).
Rate Estimates
A possible objection about the foregoing calculations is that multiple independent studies have found the FPR to be zero: should not the large number of studies reporting oFPR = 0 strengthen our confidence that bilaterally absent SSEPs results are a near-infallible predictor of poor neurologic outcome after cardiac arrest (Table 1) ? To determine the weight of this objection, we extend the foregoing analysis. Consider a study with n subjects and assume for the sake of argument that nFPR is in fact greater than zero, say 5%. It is possible in any given study that, by chance, no good outcomes will be observed. Furthermore, because most published studies involve small cohorts, such "zero numerator" outcomes should be common. In fact, assuming nFPR= 5%, the probability of zero good outcomes in a study involving n subjects is exactly p n n = ( ) = ( )
. To see this, consider that the probability of any one subject with absent SSEPs having a poor outcome is 1 095 -. nFPR
To obtain the probability that n independent subjects with absent SSEPs in a study all have poor outcomes, we multiply this probability by itself n times. Thus, in a typical study that reports outcomes for n = 20 subjects with absent SSEPs, the probability that all will have a poor outcome (i.e., "zero" good outcomes despite nFPR of 5%) is p = ( ) = 0 95 36 20 . % . Now consider the effect that early WLST has on these estimates. In this case, the probability that all observed outcomes are bad is % . Figure 4 illustrates how the probability of a zero-numerator varies with cohort size n and WLST rate, assuming a nFPR for absent SSEPs of 5%. We note that the probability that all observed outcomes after an initial absent SSEPs will be poor increases with higher rates of self-fulfilling prophecies and decreases with larger samples sizes. The probability of a misleading study (zero-numerator result) remains high even for relatively large studies, although small studies are most vulnerable to this problem.
DISCUSSION
Our systematic review adds 12 cases to the two reports found in previous systematic reviews who had good neurologic outcome after cardiac arrest despite bilateral absent cortical SSEP N20 responses (5, 6, (42) (43) (44) (45) . We find that much of the literature supporting some of the neurology community's belief in a "zero" false positive prediction rate for SSEPs is biased: the majority of published estimates of the FPR of absent SSEPs are confounded by high rates of WLST or policies in which absent SSEPs systematically results in WLST. Our analysis suggests that, after correcting for early WLST, the FPR of absent SSEPs may be an order of magnitude higher than commonly supposed: 7.7%, rather than 0.7% (3). This estimate is necessarily tentative given the heterogeneity of the pooled data. Nevertheless, our findings argue that published estimates of the FPR for absent SSEPs as a predictor of poor neurologic outcome should be considered subject to substantial uncertainty. Thus, using absent SSEPs in isolation to predict poor prognosis and systematically recommend WLST is unwarranted.
Evidence-based guidelines recommend a multimodal approach to prognostication in cardiac arrest and suggest that a combination of poor prognostic signs, such as absent pupillary responses after 72 hours and absent SSEPs during normothermia, have a FPR of 0-0.7% (3, 4) . However, these estimates are based on studies that fall prey to the same potential bias discussed throughout this review. Although a multimodal approach should in principle improve predictions, the statistical problems are even more challenging than for absent SSEPs alone as the literature necessarily contains fewer instances of such compound events. Consequently, it is not possible to accurately estimate the FPR of a multimodal assessment from existing studies. Furthermore, most neurologic examination findings and test results in subjects with coma after cardiac arrest are correlated rather than independent. The case reports from Karunasekara et al (23) and Weinstein et al (32) illustrate how difficult prognostication can be despite multiple poor prognostic markers (Table 1 ). In the former, the patient had a pulseless electric activity, status epilepticus, and absent SSEPs; however, had a normal brain MRI and ultimately had a good outcome. The patient in the Weinstein et al (32) report had abdominal and upper extremity myoclonus, generalized periodic discharges on the electroencephalogram, and absent SSEPs. A reasonable approach to multimodal prognostication would be to also focus on the identification of biomarkers of potential for functional recovery such as electroencephalogram reactivity and auditory discrimination (46, 47) . Identifying signs of early neurologic recovery that precede examination improvement may increase the likelihood to continue intensive supportive care and consequently potentially promote survival with good neurologic function. Although tempting, the assumption that a combination of poor prognostic markers is infallible remains unproven, and the FPR needs to measured in a prospective study that integrates clinical, neuroimaging, electrophysiology, SSEPs, and serum biomarkers, while also taking measures to minimize self-fulfilling prophecies bias.
Timing, medication use, and technician-reviewer expertise are among the many caveats often overlooked in SSEPs interpretation. We identified five cases with good outcome that initially had absent cortical responses and afterward recovered N20 responses on repeat testing-two recovered cortical responses soon after cooling was completed and two, just a few days after (5, 12, 18, 23) . This observation contrasts with reports suggesting that effects of sedation and therapeutic hypothermia at 32-34°C do not influence SSEPs results (40, 41) . Additionally, interrater reliability of SSEP testing is limited, especially for patterns predicting poor outcome (27, 34) . This issue is well illustrated by Bouwes et al (7) , who performed a secondary review of SSEPs from subjects who had good outcome despite absent cortical N20 responses. These authors concluded that the original SSEP assessments for the three survivors with absent SSEPs may have been inaccurate. However, rather than showing that absent SSEPs in the rare cases that do survive are flukes, this reminds us that SSEP testing performed in real-world clinical practice is subject to technical and human error, further reason to regard them as imperfect standalone outcome predictors. This argument also serves to emphasize the need for both high technical and interpretation quality standards in SSEP testing to determine absence of cortical responses with confidence. Repeating SSEPs after identifying an absent N20 response or providing the amplitude of the N20 response instead of using a binary classification without an amplitude criterion for presence or absence of a response might help minimize misclassifications (5, 15, 17) .
As for any systematic review, our study has several important limitations. First, the quality of evidence provided in this review is constrained by the inherent variability in local practices and subject characteristics of the studies included. Not all subjects evaluated had evoked potentials tested, and SSEPs were performed at different times and temperature levels using various analgesia, sedation and muscle blockade protocols. More importantly, several studies did not report a specific protocol for when to proceed with it. The lack of uniformity in ancillary testing procedures and WLST decisions highlights prevailing controversies about prognostication best practices in cardiac arrest. Additionally, the specific rate of WLST was not reported in the majority of the studies, therefore our estimation based on protocol descriptions is necessarily approximate. Second, only one study had the treating team blinded to SSEP results, underscoring the risk of self-fulfilling prophecies in the majority of studies. Third, we defined "adequate period of observation" for decisions regarding WLST due to poor neurologic prognosis as 7 days. Although arbitrary, using a specific number was necessary to appraise the literature and attempt to separate studies prone to bias from study attrition related to early WLST. Fourth, the statistical assumption for our FPR analysis is that life support is withdrawn equally at random amongst patients with absent SSEPs.
There are other limitations of our study regarding statistical issues that should be noted. The formulas for computing joint probabilities of WLST occurrence and outcome assume the two events are essentially independent. This is reasonable to the extent that WLST among patients with absent SSEPs are influenced by factors independent of outcome such as religious or moral reasons, variation in physician biases, and practice variation between hospitals. However, it is also possible that physicians somehow accurately discriminate via "clinical intuition" between patients with bilaterally absent SSEPs who have a lower probability versus higher probability of survival, and thereupon use this in decisions regarding WLST. Another limitation is that data at the patient level for our study was pooled across studies. This limitation is mitigated to some extent by the fact that the records and events of interest were widely distributed across studies. Lastly, our analysis did not incorporate the time of WLST relative to the time of ROSC or SSEPs assessment. All things being equal, WLST earlier in time may have been more likely to censor a possible observation of a good outcome than WLST implemented later. To overcome some of these problems, future work might use an "event history" approach using survival analysis in which WLST is regarded as a censored observation, and "studies" are considered a random factor. Relevant demographic and clinical covariates, and prognostic indicators known to be predictive of a bad outcome, could be included in the model. The latter would help control and stratify for the confounding of WLST with an underlying higher probability of a bad outcome. Unfortunately, for our systematic review, we were not able to obtain detailed covariates or time-to-event data at the patient level for most studies examined.
Our findings suggest that treating absent cortical responses on SSEPs as a biomarker with near-zero FPR is inadequate. Prognostic uncertainty is more pronounced than commonly appreciated, underscoring the risk that misguided WLST due to absent SSEPs may lead to death in patients who might otherwise have survived and regained independence. An approach to avoid self-fulfilling prophecies and determine the true diagnostic accuracy of SSEPs and other prognostic markers would be to design a study that precludes self-fulfilling prophecies, for example, by systematically postponing WLST for at least 2 weeks. Between 380 and 4,898 patients with absent SSEPs would be needed to estimate the FPR of absent SSEPs with a precision margin of error (MOE of ± 1%, if the actual value to be estimated lies between 1% and 15% (the number needed, n, depends on true value of the underlying FPR: n = ( )( ) FPR 1 FPR 1.96/MOE − 2 ). This type of study design could potentially be executed in countries where WLST is not a usual practice.
In the absence of a definitive study, a pragmatic approach would be to avoid the pretense that SSEPs-or any other ancillary test-can, in isolation, predict outcomes with certainty. Although for some caregivers a 95%, or even 90% or lower, probability of poor outcome despite intensive medical care is sufficient to support that WLST is the preferred course of action, to others, this degree of uncertainty may dictate continuing life support despite the presence of poor prognostic markers. In either scenario, informed decisions do not require FPR of 0%, and individualized decisionmaking can proceed without requiring assurance of absolute certainty.
CONCLUSIONS
The 14 reports of good neurologic outcomes in patients with hypoxic-ischemic coma despite lack of bilateral cortical responses on SSEPs demonstrate that absent SSEPs are not infallible predictors of poor outcome. Overconfidence in the prognostic accuracy of absent SSEPs is likely influenced by low estimates of the FPR for absent SSEPs, which are biased by self-fulfilling prophecies involving WLST. Our analysis suggests the that, after adjusting for early WLST, the FPR may be several times higher than generally believed. Similar to other poor prognosis markers previously but no longer believed to be unequivocal, these findings indicate that decisions regarding early WLST should not be solely determined by SSEPs results (3, 4, 7, 36) .
